Daily MaverickSIGNED AND SEALED: Balti-maul — Springboks win series 3-1 over All Blacks after US victoryESPNOSU stuns No. 6 Oregon, ending 21-game FBS skidThe Jerusalem PostSwedes vote in election that could usher far right into governmentInquirerPolice arrest two DI-linked teens after shootout in MaguindanaoESPN DeportesLa Novena de MLB: La vuelta de Volpe, las Kardashian y la "sugerencia" de PujolsPunchSleeping with earbuds may trigger hearing loss, say ENT specialistsCNN TürkMersin'de otomobil ile hafif ticari aracın çarpıştığı kazada 1 çocuk öldü, 6 kişi yaralandıLa NaciónÚltimas encuestas en Florida: Jolly mantiene la ventaja frente a Donalds y se acerca la elección del 3 de noviembre한겨레북 치고 촛불 ‘후~’…장동혁, ‘올공 100일’ 자축 “우리는 전사”20 Minuten«Ich war im Jugendknast – heute habe ich Familie, ein Haus, Geld»UOLFolha lança portal C-Level e amplia cobertura de negócios e finançasSözcüAKP’ye geçen Bingöl’ün iddiaları Meclis’e geldi
The Daily Newsstand · Free, Always
Sunday, September 13, 2026

Walgreens retreats as CVS quietly takes over suburban pharmacies

Translate

Drive through almost any American suburb, and you will spot it: a shuttered Walgreens with a handwritten sign in the window telling customers their prescriptions moved down the road. More often than not, that road leads to a CVS.

This pattern is playing out in strip malls across the country, quietly reshaping who controls the neighborhood pharmacy business without either company having to compete openly.

Walgreens is not trimming a handful of weak stores. It is closing roughly 1,200 of its approximately 8,500 U.S. locations through 2027.

CVS (CVS), meanwhile, is opening new stores and absorbing customers who no longer have a choice.

Walgreens stock exits public markets amid closures

In August 2025, Walgreens completed a $10 billion sale to private equity firm Sycamore Partners, taking the 124-year-old chain private for the first time.

According to a company statement, Mike Motz was named chief executive, replacing Tim Wentworth, who will stay on as a director. John Lederer, a senior advisor to Sycamore, became executive chairman.

"As a private organization, alongside our dedicated team members, we are renewing our focus on our core pharmacy and retail platform, our stores and our customer experience," Motz stated.

Related: Pharmacy giant closes more stores across U.S. in 2026

Going private removed Walgreens stock from the daily scrutiny of Wall Street, and that freedom appears to have sped up the closures.

Company leadership has pointed to shrinking pharmacy reimbursement rates, weaker retail traffic, and competition from Amazon Pharmacy as reasons roughly a quarter of stores no longer fit the chain's strategy.

CVS stock benefits without lifting a finger

CVS has not needed a marketing campaign or a price war to gain ground.

Federal and state rules require an orderly transfer of prescription records when a pharmacy closes, and in several markets, these scripts land at the nearest CVS.

Decades of overlapping suburban footprints mean a Walgreens closing is often just a mile or two from an open CVS door.

Foot traffic data shows how sticky the trend has become. Even as both chains shrink their overall store counts, the combined share of pharmacy visits keeps climbing.

More Retail:

CVS and Walgreens together now handle nearly 40% of all U.S. retail prescription sales.

CVS also has a structural edge. Its ownership of Caremark, one of the three dominant pharmacy benefit managers in the country, gives it a vertically integrated advantage that helps absorb reimbursement pressure that hits pure retail operators harder.

View the original on Yahoo Finance

KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.